GATC Acquires SOLiD™ DNA Sequencer from Applied Biosystems
Complete the form below to unlock access to ALL audio articles.
GATC Biotech has announced the acquisition of a SOLiD™ DNA sequencing system from Applied Biosystems.
The system will be the third next generation sequencing technology to be installed in GATC's German research facility in Constance, which currently holds the GS FLX™ from Roche Diagnostics as well as the Genome Analyzer™ from Illumina.
According to GATC, being a part of Applied Biosystems' Early-Access Program, the SOLiD™ System is expected to be installed in early autumn this year and will boost the company's current sequencing capacity from 130 gigabases to 250 gigabases a year.
Therefore GATC will be the first and only commercial sequencing service provider worldwide being able to offer ultra high-throughput DNA analysis using all three leading next generation sequencing technologies, the company says. The total investment exceeds 2 million Euros.
